GSK Advances mRNA Flu Vaccine to Phase III After Data
LONDON, UK, Sept. 1, 2026 GSK announced that it will advance its investigational mRNA seasonal influenza vaccine candidate into...
Vaccines
Advertisement
Pfizer and BioNTech Win FDA Approval for XFG COVID-19 Vaccine
NEW YORK, NY and MAINZ, Germany – August 27, 2026 Pfizer Inc. and BioNTech SE announced that the U.S....
GSK Invests £400M in Cambridge R&D Innovation Centre
LONDON, July 30, 2026 GSK has announced plans to establish a new global flagship research and development (R&D) centre...
GSK Accelerates R&D After Strong Q2 2026 Performance
LONDON, July 30, 2026 GSK has reported strong Q2 2026 financial results, driven by continued growth across its Specialty...
Aptar Pharma Launches Injectable Drug Development Framework
Crystal Lake, Ill., July 17, 2026 Aptar Pharma announced the launch of a new integrated system-level framework designed to...
Advertisements
Merck’s CAPVAXIVE Wins FDA Approval for High-Risk Children
RAHWAY, N.J., June 18, 2026 Merck announced that the U.S. Food and Drug Administration (FDA) has approved an expanded...
Thermo Fisher Opens US Bioprocess Center to Boost Biologics
WALTHAM, Massachusetts, USA, April 28, 2026 Thermo Fisher Scientific has announced the opening of its flagship U.S. Bioprocess Design...
Sanofi Expands Sanofi Ventures With $625M to Drive Biotech Innovation
PARIS, Sept. 24, 2025 — Sanofi announced a $625 million capital expansion for its corporate venture fund, Sanofi Ventures,...
Merck’s CAPVAXIVE Shows Strong Immune Response in Children
RAHWAY, N.J. – September 11, 2025 – Merck (NYSE: MRK), known as MSD outside the United States and Canada,...
Advertisement
